Ubs Group Ag Neurosense Therapeutics LTD Wt Transaction History

Ubs Group Ag

$611 Billion
Q3 2025

A detailed history of Ubs Group Ag transactions in Neurosense Therapeutics LTD Wt stock. As of the latest transaction made, Ubs Group Ag holds 1,280 shares of NRSNW stock, worth $371. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,280

Previous 1,470 12.93%

Holding current value

$371

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	SELL	$0.35 - $0.89 $66 - $169	-190 Reduced 12.93%	1,280 $0
Q2 2025 Aug 14, 2025	SELL	$0.18 - $0.85 $246 - $1,165	-1,371 Reduced 48.26%	1,470 $0
Q1 2025 May 13, 2025	BUY	$0.2 - $0.53 $549 - $1,455	2,747 Added 2922.34%	2,841 $0
Q4 2024 Feb 14, 2025	SELL	$0.12 - $0.5 $12 - $53	-106 Reduced 53.0%	94 $0
Q3 2024 Nov 14, 2024	SELL	$0.13 - $0.27 $52 - $109	-405 Reduced 66.94%	200 $0

Q2 2024 Aug 13, 2024	BUY	$0.1 - $0.5 $60 - $302	605 New	605 $0
Q3 2023 Nov 09, 2023	BUY	$0.11 - $0.28 $418 - $1,064	3,802 New	3,802 $0
Q4 2022 Feb 08, 2023	SELL	$0.16 - $0.44 $185 - $510	-1,160 Reduced 59.24%	798 $0
Q3 2022 Nov 10, 2022	BUY	$0.19 - $0.4 $372 - $783	1,958 New	1,958 $0
Q1 2022 May 16, 2022	SELL	$0.26 - $1.15 $1,167 - $5,164	-4,491 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$0.67 - $1.15 $3,008 - $5,164	4,491 New	4,491 $4,000

Others Institutions Holding NRSNW

# of Institutions

Shares Held

289K

Call Options Held

Put Options Held

View Full List

About NEUROSENSE THERAPEUTICS LTD WT

Ticker NRSNW

More about NRSNW

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Account